questionsmedicales.fr
Maladies du système nerveux
Maladies du système nerveux central
Troubles de la motricité
Syndromes parkinsoniens
Syndromes parkinsoniens : Questions médicales fréquentes
Termes MeSH sélectionnés :
Protein Processing, Post-Translational
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndromes parkinsoniens : Questions médicales les plus fréquentes",
"headline": "Syndromes parkinsoniens : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndromes parkinsoniens : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-25",
"dateModified": "2025-04-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndromes parkinsoniens"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles de la motricité",
"url": "https://questionsmedicales.fr/mesh/D009069",
"about": {
"@type": "MedicalCondition",
"name": "Troubles de la motricité",
"code": {
"@type": "MedicalCode",
"code": "D009069",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.662"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndrome parkinsonien secondaire",
"alternateName": "Parkinson Disease, Secondary",
"url": "https://questionsmedicales.fr/mesh/D010302",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome parkinsonien secondaire",
"code": {
"@type": "MedicalCode",
"code": "D010302",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.662.600.700"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Maladie de Parkinson post-encéphalitique",
"alternateName": "Parkinson Disease, Postencephalitic",
"url": "https://questionsmedicales.fr/mesh/D010301",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Parkinson post-encéphalitique",
"code": {
"@type": "MedicalCode",
"code": "D010301",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.662.600.700.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Syndromes parkinsoniens",
"alternateName": "Parkinsonian Disorders",
"code": {
"@type": "MedicalCode",
"code": "D020734",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sara Hall",
"url": "https://questionsmedicales.fr/author/Sara%20Hall",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden."
}
},
{
"@type": "Person",
"name": "Shorena Janelidze",
"url": "https://questionsmedicales.fr/author/Shorena%20Janelidze",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden."
}
},
{
"@type": "Person",
"name": "Oskar Hansson",
"url": "https://questionsmedicales.fr/author/Oskar%20Hansson",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden."
}
},
{
"@type": "Person",
"name": "Hash Brown Taha",
"url": "https://questionsmedicales.fr/author/Hash%20Brown%20Taha",
"affiliation": {
"@type": "Organization",
"name": "Department of Integrative Biology and Physiology, University of California Los Angeles, Los Angeles, CA, USA."
}
},
{
"@type": "Person",
"name": "Carlo Colosimo",
"url": "https://questionsmedicales.fr/author/Carlo%20Colosimo",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Santa Maria University Hospital, Terni, Italy. Electronic address: carlo.colosimo@uniroma1.it."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A Chemical Mutagenesis Approach to Insert Post-translational Modifications in Aggregation-Prone Proteins.",
"datePublished": "2022-05-24",
"url": "https://questionsmedicales.fr/article/35609278",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acschemneuro.2c00077"
}
},
{
"@type": "ScholarlyArticle",
"name": "Post-Translational Modifications of Proteins in Cytosolic Nucleic Acid Sensing Signaling Pathways.",
"datePublished": "2022-06-20",
"url": "https://questionsmedicales.fr/article/35795661",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.898724"
}
},
{
"@type": "ScholarlyArticle",
"name": "Modeling Side Chains in the Three-Dimensional Structure of Proteins for Post-Translational Modifications.",
"datePublished": "2023-08-30",
"url": "https://questionsmedicales.fr/article/37686234",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241713431"
}
},
{
"@type": "ScholarlyArticle",
"name": "Multi-protein assemblies orchestrate co-translational enzymatic processing on the human ribosome.",
"datePublished": "2024-09-03",
"url": "https://questionsmedicales.fr/article/39227397",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-024-51964-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Protein Kinases and Cross-talk between Post-translational Modifications in the Regulation of Drug Transporters.",
"datePublished": "2022-10-27",
"url": "https://questionsmedicales.fr/article/36302660",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1124/molpharm.122.000604"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002493"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles de la motricité",
"item": "https://questionsmedicales.fr/mesh/D009069"
},
{
"@type": "ListItem",
"position": 5,
"name": "Syndromes parkinsoniens",
"item": "https://questionsmedicales.fr/mesh/D020734"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndromes parkinsoniens - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndromes parkinsoniens",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndromes parkinsoniens",
"description": "Comment diagnostiquer un syndrome parkinsonien ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels sont les critères de diagnostic ?\nPeut-on confondre avec d'autres maladies ?\nQuel rôle joue l'historique médical ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndromes parkinsoniens",
"description": "Quels sont les symptômes moteurs principaux ?\nQuels symptômes non moteurs sont fréquents ?\nComment évoluent les symptômes ?\nY a-t-il des symptômes précoces ?\nLes symptômes affectent-ils la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndromes parkinsoniens",
"description": "Peut-on prévenir les syndromes parkinsoniens ?\nQuel rôle joue l'exercice physique ?\nL'alimentation influence-t-elle le risque ?\nY a-t-il des facteurs environnementaux à considérer ?\nLe stress a-t-il un impact ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndromes parkinsoniens",
"description": "Quels sont les traitements médicamenteux ?\nLa chirurgie est-elle une option ?\nQuels sont les effets secondaires des médicaments ?\nY a-t-il des thérapies complémentaires ?\nComment gérer les symptômes non moteurs ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndromes parkinsoniens",
"description": "Quelles sont les complications courantes ?\nComment les chutes affectent-elles les patients ?\nLes troubles cognitifs sont-ils fréquents ?\nQuelles sont les complications psychologiques ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndromes parkinsoniens",
"description": "Quels sont les principaux facteurs de risque ?\nLe sexe influence-t-il le risque ?\nLes traumatismes crâniens sont-ils un facteur ?\nL'exposition professionnelle joue-t-elle un rôle ?\nY a-t-il des liens avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un syndrome parkinsonien ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et l'évaluation des symptômes moteurs et non moteurs."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie comme l'IRM et des évaluations neuropsychologiques peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la bradykinésie, la rigidité et les tremblements au repos."
}
},
{
"@type": "Question",
"name": "Peut-on confondre avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la maladie de Wilson ou des syndromes atypiques peuvent être confondues."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des facteurs de risque et des symptômes précurseurs."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes moteurs principaux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes moteurs incluent la bradykinésie, la rigidité, et les tremblements."
}
},
{
"@type": "Question",
"name": "Quels symptômes non moteurs sont fréquents ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes non moteurs incluent la dépression, l'anxiété et les troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Comment évoluent les symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes évoluent progressivement, souvent en s'aggravant avec le temps."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes précoces ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la perte de l'odorat ou des troubles du sommeil peuvent apparaître tôt."
}
},
{
"@type": "Question",
"name": "Les symptômes affectent-ils la qualité de vie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent considérablement réduire la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les syndromes parkinsoniens ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention garantie, mais un mode de vie sain peut aider."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'exercice physique ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier peut améliorer la santé neurologique et retarder l'apparition des symptômes."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants peut réduire le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à considérer ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains pesticides et toxines peut augmenter le risque de Parkinson."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut aggraver les symptômes et influencer la progression de la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements médicamenteux ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la lévodopa, les agonistes de la dopamine et les inhibiteurs de la COMT."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la stimulation cérébrale profonde peut être envisagée pour certains patients."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des vertiges et des mouvements involontaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies complémentaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie et l'ergothérapie peuvent aider à améliorer la fonction motrice."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes non moteurs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements psychologiques et des médicaments peuvent aider à gérer les symptômes non moteurs."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications courantes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les chutes, les troubles de la déglutition et les infections."
}
},
{
"@type": "Question",
"name": "Comment les chutes affectent-elles les patients ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les chutes peuvent entraîner des blessures graves, comme des fractures, et réduire l'autonomie."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils fréquents ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux patients développent des troubles cognitifs ou démence au cours de la maladie."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications psychologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent souffrir de dépression, d'anxiété et d'isolement social."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire est essentielle pour gérer les complications efficacement."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, les antécédents familiaux et l'exposition à des toxines."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes sont généralement plus susceptibles de développer des syndromes parkinsoniens."
}
},
{
"@type": "Question",
"name": "Les traumatismes crâniens sont-ils un facteur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traumatismes crâniens répétés peuvent augmenter le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle joue-t-elle un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines professions exposant à des produits chimiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des liens avec d'autres maladies ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies auto-immunes et métaboliques peuvent être associées à un risque accru."
}
}
]
}
]
}
Neurodegenerative diseases are a class of disorders linked to the formation in the nervous system of fibrillar protein aggregates called amyloids. This aggregation process is affected by a variety of ...
The innate immune response is the first-line host defense against pathogens. Cytosolic nucleic acids, including both DNA and RNA, represent a special type of danger signal to initiate an innate immune...
Amino acid substitutions and post-translational modifications (PTMs) play a crucial role in many cellular processes by directly affecting the structural and dynamic features of protein interaction. De...
Nascent chains undergo co-translational enzymatic processing as soon as their N-terminus becomes accessible at the ribosomal polypeptide tunnel exit (PTE). In eukaryotes, N-terminal methionine excisio...
Drug transporters are modulators for drug absorption, distribution, and excretion. Key drug transporters including P-glycoprotein and breast cancer resistance protein of the ABC superfamily; organic a...
Facioscapulohumeral muscular dystrophy (FSHD) is caused by abnormal de-repression of the myotoxic transcription factor DUX4. Although the transcriptional targets of DUX4 are known, the regulation of D...
We immunoprecipitated DUX4 protein and performed mass spectrometry to identify PTMs. We then characterized DUX4 PTMs and potential enzyme modifiers using mutagenesis, proteomics, and biochemical assay...
We identified 17 DUX4 amino acids with PTMs, and generated 55 DUX4 mutants designed to prevent or mimic PTMs. Five mutants protected cells against DUX4-mediated toxicity and reduced the ability of DUX...
These results support that DUX4 is regulated by PTMs and set a foundation for developing FSHD drug screens based mechanistically on DUX4 PTMs and modifying enzymes. ANN NEUROL 2023;94:398-413....
In this review, we extensively describe the main post-translational modifications that give rise to the multiple proteoforms characterized to date in the human salivary proteome and their potential ro...
The post-translational modifications of conopeptides are the most complicated modifications to date and are well-known and closely related to the activity of conopeptides. The hydroxylation of proline...
Post-translational modifications (PTMs) play key roles in regulating cell signaling and physiology in both normal and cancer cells. Advances in mass spectrometry enable high-throughput, accurate, and ...
Post-translational modifications (PTMs) are chemical modifications that can regulate the activity and function of proteins. From an evolutionary perspective, they also represent a fast mechanism for t...